Screening of fetal trisomies 21, 18 and 13 by non-invasive prenatal testing

Home  /  National Uptake and Case Studies  /  Screening of fetal trisomies 21, 18 and 13 by non-invasive prenatal testing
CountryAgencyYear work was carried outLinkDetails of use
SpainAETSAOngoingAt a regional level, the report is going to be distributed to decision-makers.
SpainAQUASOngoingThe OTCA03 assessment will be disseminated to Catalan regional decision makers (physicians societies and Health Services Planners)
SpainAvalia-t2018 - 2019The adaptation of the NIPT assessment and the development of the national screening policy for prenatal screening was included in the 2018 work plan of the Spanish Network of HTA agencies. The NIPT assessment is being summarised and translated, and the hypothetical models are being used to estimate the real cost impact of the different NIPT strategies. This work will be used as the basis for decision making regarding inclusion in the national health care portfolio.
SpainOSTEBA2018The OTCA03 assessment was disseminated to the Manager of the Prenatal Screening Programme within the Basque Health Service, to gynaecologists and to other decision makers.
UKNICE2018https://www.evidence.nhs.uk/search?q=EUnetHTA EUnetHTA reports are indexed in NHS evidence a database managed by NICE that supports evidence informed decision making in the NHS